Heterocephalus glaber (naked mole-rat): 101715321
Help
Entry
101715321 CDS
T02812
Symbol
Plcg2
Name
(RefSeq) phospholipase C gamma 2
KO
K05859
phosphatidylinositol phospholipase C, gamma-2 [EC:
3.1.4.11
]
Organism
hgl
Heterocephalus glaber (naked mole-rat)
Pathway
hgl00562
Inositol phosphate metabolism
hgl01100
Metabolic pathways
hgl01521
EGFR tyrosine kinase inhibitor resistance
hgl04012
ErbB signaling pathway
hgl04014
Ras signaling pathway
hgl04020
Calcium signaling pathway
hgl04062
Chemokine signaling pathway
hgl04064
NF-kappa B signaling pathway
hgl04066
HIF-1 signaling pathway
hgl04070
Phosphatidylinositol signaling system
hgl04072
Phospholipase D signaling pathway
hgl04360
Axon guidance
hgl04370
VEGF signaling pathway
hgl04380
Osteoclast differentiation
hgl04611
Platelet activation
hgl04613
Neutrophil extracellular trap formation
hgl04625
C-type lectin receptor signaling pathway
hgl04650
Natural killer cell mediated cytotoxicity
hgl04662
B cell receptor signaling pathway
hgl04664
Fc epsilon RI signaling pathway
hgl04666
Fc gamma R-mediated phagocytosis
hgl04670
Leukocyte transendothelial migration
hgl04722
Neurotrophin signaling pathway
hgl04750
Inflammatory mediator regulation of TRP channels
hgl04919
Thyroid hormone signaling pathway
hgl04933
AGE-RAGE signaling pathway in diabetic complications
hgl04935
Growth hormone synthesis, secretion and action
hgl05167
Kaposi sarcoma-associated herpesvirus infection
hgl05169
Epstein-Barr virus infection
hgl05170
Human immunodeficiency virus 1 infection
hgl05171
Coronavirus disease - COVID-19
hgl05200
Pathways in cancer
hgl05205
Proteoglycans in cancer
hgl05206
MicroRNAs in cancer
hgl05214
Glioma
hgl05223
Non-small cell lung cancer
hgl05225
Hepatocellular carcinoma
Module
hgl_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
hgl00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
101715321 (Plcg2)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
101715321 (Plcg2)
04014 Ras signaling pathway
101715321 (Plcg2)
04370 VEGF signaling pathway
101715321 (Plcg2)
04064 NF-kappa B signaling pathway
101715321 (Plcg2)
04066 HIF-1 signaling pathway
101715321 (Plcg2)
04020 Calcium signaling pathway
101715321 (Plcg2)
04070 Phosphatidylinositol signaling system
101715321 (Plcg2)
04072 Phospholipase D signaling pathway
101715321 (Plcg2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
101715321 (Plcg2)
04613 Neutrophil extracellular trap formation
101715321 (Plcg2)
04625 C-type lectin receptor signaling pathway
101715321 (Plcg2)
04650 Natural killer cell mediated cytotoxicity
101715321 (Plcg2)
04662 B cell receptor signaling pathway
101715321 (Plcg2)
04664 Fc epsilon RI signaling pathway
101715321 (Plcg2)
04666 Fc gamma R-mediated phagocytosis
101715321 (Plcg2)
04670 Leukocyte transendothelial migration
101715321 (Plcg2)
04062 Chemokine signaling pathway
101715321 (Plcg2)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
101715321 (Plcg2)
04919 Thyroid hormone signaling pathway
101715321 (Plcg2)
09156 Nervous system
04722 Neurotrophin signaling pathway
101715321 (Plcg2)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
101715321 (Plcg2)
09158 Development and regeneration
04360 Axon guidance
101715321 (Plcg2)
04380 Osteoclast differentiation
101715321 (Plcg2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
101715321 (Plcg2)
05206 MicroRNAs in cancer
101715321 (Plcg2)
05205 Proteoglycans in cancer
101715321 (Plcg2)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
101715321 (Plcg2)
05214 Glioma
101715321 (Plcg2)
05223 Non-small cell lung cancer
101715321 (Plcg2)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
101715321 (Plcg2)
05171 Coronavirus disease - COVID-19
101715321 (Plcg2)
05167 Kaposi sarcoma-associated herpesvirus infection
101715321 (Plcg2)
05169 Epstein-Barr virus infection
101715321 (Plcg2)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
101715321 (Plcg2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
101715321 (Plcg2)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
hgl04131
]
101715321 (Plcg2)
Enzymes [BR:
hgl01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
101715321 (Plcg2)
Membrane trafficking [BR:
hgl04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
101715321 (Plcg2)
Endocytosis
Macropinocytosis
Phospholipase C
101715321 (Plcg2)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
EF-hand_PLCG2
C2
SH3_1
SH3_9
SH2_1
EF-hand_PLCG1
PH_12
PH
EF-hand_like
PH_14
Motif
Other DBs
NCBI-GeneID:
101715321
NCBI-ProteinID:
XP_004843278
LinkDB
All DBs
Position
Un
AA seq
1195 aa
AA seq
DB search
MTTMVDVDALPEYEKSQIKRALELGTVMTVFSFRKSTPERRTVQVIMETRQVAWSKTADK
IEGFLDIMEIKEIRPGKNSKDFERAKAVRQKEDCCFTILYGTHFVLSTLSLATDSREDAI
MWLSGLKILHQEVMSASTPTIIESWLRKQIYSVDQTRRNSISLRELKAILPLVNFKVSSA
KFLKDKLVEISAHKDELSFEQFHLFYKKLMFEQQKLILDEFKKDSSVFILGNTDRPDASA
VYLQDFQRFLVHEQQELWAQDVNKVREQMTKFIDDTMRETAEPFLFVDEFLMYLFSRENS
IWDGKHDVVDMQDMNNPLSHYWISSSHNTYLTGDQLRSESSTEAYIRCLRMGCRCIELDC
WDGPDGKPIIYHGWTRTTKIKFDDVVQAIRDHAFVTSSFPVILSIEEHCSVEQQRHMARM
FKEVLGELLLTKPTEASADQLPSPSQLREKIIIKHKKLGPRGDVDVNVEDKKDEHKQQGE
LYMWDSIDQKWTRHYCAIADAKLSFSDDIEQAAEEELSQDLPPMELHLREKWFHKKMEKR
TNAEKLLQEYCAEAGAKDGTFLVRESESHPNAYTLSFWRSGRVQHCLIRSTLENGAMKYY
LTDNLKFSSIYDLIQHYRESHLRCAEFELRLTDPVPNPNPHESKPWYYDGLSRGEAEDML
MRIPRDGAFLIRKREKKHEGLEDSYAITFRARGKVKHCRINRDGRHFVLGTSAYFESLVE
LVSYYEKHTLYRKMRLRYPVTPELLERYNMERDINSLYDVSRMYVDPSEINPSMPQRTVK
ALYDYEAKHSDELSXCRGALIHNVSKEPGGWWKGDYGTRIQQYFPSNYVEDISTADGEEL
EKQENNMKYWEKNQSIAIELSDLVVYCKPTSKTKDNLENPDFREIRSFVETKADSIIRQK
PEDLLRYNQKGLTRIYPKGQRVDSSNYDPFRLWLCGSQMVALNFQTADKYMQLNHALFSL
NGRTGYVLQPEIMRTGKYDPMPPESQRKIQMTLTIKVLGARHLPKPGRSIACPFVEVEIC
GAEYDNNKFKTTVVNDNGLSPVWAPTQEKVTFEIYDPNLAFLRFVVYEEDIFSDPNFLAH
ATYPIKGIKSGFRSVPLKNGYSEDIELASLLVFCEMRPVLESEEELYSSCRQLRRRQEEL
NNQLFLYDTHQNLRNANRDALVKEFNVNENQLQLYQEKCNRRLREKRVSNSKFYS
NT seq
3588 nt
NT seq
+upstream
nt +downstream
nt
atgaccaccatggtcgatgtggacgcccttccggaatacgagaagagtcagatcaagcga
gccctggagctggggacggtcatgacggtgttcagcttccgaaagtccacccctgagcgg
aggacagtccaggtgatcatggaaacgaggcaggtggcctggagcaagactgcggacaag
atcgagggcttcttggatatcatggaaatcaaggaaattcgcccagggaagaactccaag
gacttcgagcgtgcaaaagcagtccgccagaaggaagactgctgcttcaccatcttgtac
ggcacccatttcgtcctcagcacactcagtttggcaactgactccagagaggatgcaatt
atgtggctctcaggcctgaaaatcttgcaccaggaagtgatgagcgcatccacgcccact
atcatagagagttggctgagaaaacagatttattctgtagatcaaaccagaagaaacagc
atcagcctccgagagttgaaggccatcctacccctggtcaacttcaaagtgagcagtgcc
aagttcctcaaagataagcttgtggaaattagtgcacacaaagacgaactcagctttgag
cagtttcatctcttctataaaaaacttatgtttgagcagcaaaaactgattcttgacgaa
ttcaaaaaggattcctccgtgtttatcctggggaacactgaccgacctgatgcctctgcc
gtttacctgcaggacttccagaggtttcttgtacacgagcagcaggagctttgggctcag
gatgtaaacaaagtccgggagcagatgacaaagtttattgacgacaccatgagggagacg
gctgagcccttcttgtttgtggacgagttcctcatgtacctgttttcccgagaaaacagc
atctgggatgggaagcacgatgtggtggacatgcaggacatgaacaaccccttgtcccat
tactggatctcttcgtcccacaacacgtacctcacaggtgaccagctgcgcagcgagtcg
tccacagaagcctacatccgctgcttgcgcatgggctgccgctgcattgagctggactgc
tgggatgggcccgacgggaagcccattatctaccacggctggacgcggaccaccaagatc
aagttcgatgatgtcgtgcaggccatcagagaccacgccttcgtcacctcgagcttcccc
gtgatcctgtccatcgaggagcactgcagtgtggagcagcagcggcacatggccaggatg
ttcaaggaggtgcttggcgagctgctgctgaccaagcccacggaggccagcgccgaccag
ctgccctcgcccagccagctgcgggagaagatcatcatcaagcataagaagctgggcccc
cgaggtgatgtcgatgtgaacgtggaggacaagaaagatgagcacaagcaacagggtgaa
ctgtacatgtgggactccatcgaccagaagtggactcggcactactgcgccattgctgac
gccaagctgtccttcagtgacgacattgagcaggccgcggaggaggaactgtcccaggac
cttccacccatggagctgcatttgagggagaaatggttccacaagaagatggagaagagg
acgaacgcggagaagctgctgcaggagtactgtgccgaggcgggtgccaaggacggcacc
ttcctggtgcgggagagcgagagccaccccaacgcctacaccctgtccttctggcggtcg
ggccgtgtgcagcactgcctgatccgctccaccttggagaatggcgccatgaagtactac
ctgaccgacaacctcaagttcagcagcatctacgacctcatccagcactaccgagagtcg
cacctgcgctgtgccgagtttgagctgcggctgaccgacccggtgccgaaccccaaccca
catgagtccaagccgtggtactatgacgggctgagccgtggagaggcggaggacatgctg
atgcggattccccgagatggagccttcctcatccggaagcgggaaaagaagcatgaaggg
ctggaggactcctacgccatcaccttcagggccaggggcaaggtgaaacactgtcgcatc
aaccgggatggccgtcactttgtgctggggacatctgcctattttgagagcttggtggag
cttgtcagttactatgagaaacataccctctaccgaaagatgcggctgcggtaccctgtg
acccctgagctcttggagcgctacaatatggaaagagacataaactccctctatgacgtc
agcaggatgtatgtggatccgagtgagatcaacccttctatgcctcagagaaccgtgaaa
gctctgtatgactacgaagccaagcacagtgacgagctgagtnnctgccgaggtgccctc
atccacaacgtctccaaggaacccgggggctggtggaaaggagactatggcacccgaatc
cagcagtacttcccgtccaactacgtggaggacatttccacggcggatggggaggagctg
gagaagcaggagaacaacatgaagtactgggagaagaaccagtcgatcgccattgagctc
tctgacctggttgtctattgcaaaccaaccagcaaaaccaaggataacttagagaaccct
gacttccgagaaattcgctcctttgtggagacaaaggctgacagcatcatcagacagaag
cccgaggatctcttgaggtataaccagaagggcctgacccgcatctatccgaagggacag
agggttgactcttcaaactacgatccctttcgcctgtggctgtgtggttcccagatggtg
gcgctcaatttccagaccgcagacaagtacatgcagctgaatcatgcattgttttcactc
aatgggcggacgggctacgttctgcaaccagagatcatgcggacagggaagtatgacccg
atgccaccagagtcgcagcggaagatccagatgactctcaccatcaaggtcctaggtgcc
cgccacctacccaagcctggacgaagtattgcttgtccctttgtagaggtggaaatctgt
ggggcagagtatgacaacaacaagttcaagacaacagttgtgaatgacaacggcctcagc
cctgtctgggctccaacgcaggagaaggtgacatttgaaatttatgacccaaacctcgcg
tttctgcgctttgtagtttatgaggaagacatattcagcgatcccaacttcctcgctcac
gccacttatcccattaaagggatcaagtcagggtttcgatctgttcctctcaagaatggg
tacagtgaggacatcgagctggcttccctcctggttttctgtgagatgcggccagtcctg
gagagtgaggaagaactctactcctcctgtcgccagctgcggagacggcaagaagagctg
aacaaccaactatttctgtatgacacacatcagaacctgcgcaatgcgaaccgggatgcc
cttgtcaaagagttcaacgtcaatgagaaccagctccagctgtatcaggagaagtgcaat
cgaaggttgcgagagaagagagtcagcaacagcaagttctactcttag
DBGET
integrated database retrieval system